phase 2_results
saveMinistero dell'Istruzione dell'Universita e della Ricerca — Bergacyn (Phase II Trial Results)
community read0 votes
Therapy area: Gastrointestinal. Indication: Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD or NAFLD)
comments(0)
5-min edit window · permanent after that